Metformin in polycystic ovary syndrome

@article{DiamantiKandarakis2010MetforminIP,
  title={Metformin in polycystic ovary syndrome},
  author={Evanthia Diamanti-Kandarakis and Frangiskos N Economou and Sotiria Palimeri and Charikleia D Christakou},
  journal={Annals of the New York Academy of Sciences},
  year={2010},
  volume={1205}
}
Polycystic ovary syndrome (PCOS) affects 6.6–6.8% of women in reproductive age. Insulin resistance and hyperinsulinemia play a critical role in the pathogenesis of PCOS and are associated with a high risk for type 2 diabetes mellitus and cardiometabolic abnormalities. Metformin has been introduced as a therapeutic option in PCOS, targeting of cardiometabolic and reproductive abnormalities on the basis of its action on the reduction of glucose levels and the attenuation of insulin resistance… Expand

Paper Mentions

Interventional Clinical Trial
This study was performed to investigate the effects of metformin on controlled ovarian stimulation (COS), in vitro fertilization (IVF) outcomes, pregnancy outcomes, and comparison… Expand
ConditionsPolycystic Ovary Syndrome
InterventionDrug
The Effect of Metformin on Clinical Symptoms of Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. Pathophysiological mechanisms include insulin resistance, which contributes to the development ofExpand
Advances in Treatment Options for Polycystic Ovary Syndrome
TLDR
An increasing level of therapeutic sophistication is reflected in ovarian stimulation protocols judiciously using gonadotropins, gonadotropic-releasing hormone antagonists, the procedure of ovarian drilling, and assisted reproductive technologies with in vitro oocyte maturation. Expand
Polycystic Ovarian Syndrome and Response to Stimulation
TLDR
Polycystic ovary syndrome is one of the most common endocrine disorders affecting females and various regimens have been developed for the treatment ranging from lifestyle modification to clomiphene to IVF with no consensus. Expand
COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
TLDR
The manifestation of PCOS and its impact especially on reproductive function and pregnancy are profoundly affected by associated features of obesity/raised body mass index and metabolic syndrome. Expand
Combination of Melatonin and Metformin Hydrochloride for Treatment Polycystic Ovarian in Female Rats
TLDR
The treatment with a combination of metformin hydrochloride and melatonin was more effective against hormonal alterations produced by PCOS, allowing a normalization of biochemical parameters during pregnancy, than monotherapeutic treatment with these drugs. Expand
Polycystic ovary syndrome - Effect of acupuncture on insulin resistance and neuroendocrine function
TLDR
As shown in this thesis, acupuncture treatment elicits local and systemic effects which have the capacity to break the vicious circle of androgen excess, ovarian dysfunction and possibly reduced insulin sensitivity in PCOS. Expand
Reproductive endocrinology: Metformin or thiazolidinedione therapy in PCOS?
Insulin resistance has a key role in the pathogenesis of polycystic ovary syndrome, a common endocrinopathy that affects young women. Therefore, the use of insulin-sensitizing agents has been studiedExpand
Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity.
TLDR
The improvement of mitochondrial integrity and platelet reactivity may contribute to the beneficial effects of metformin on cardiovascular disease. Expand
Polycystic ovary syndrome: Studies of affective symptoms in association with sex steroids and evaluation of electroacupuncture and physical exercise
TLDR
This thesis supports the effects of low-frequency EA and physical exercise to be partly mediated via the sympathetic nervous system for treatment of affective symptoms in women with PCOS. Expand
The impact of obesity and fitness on endothelial function in polycystic ovarian syndrome
TLDR
The primary aim of this thesis was to examine nitric oxide (NO)-mediated endothelial function at different levels of the vascular tree in women with PCOS and to establish whether supervised exercise training induces a therapeutic effect on endothelialfunction. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
TLDR
The uses of metformin are analyzed not only for the treatment of all PCOS-related disturbances such as menstrual disorders, anovulatory infertility, increased abortion, or complicated pregnancy risk, hyperandrogenism, endometrial, metabolic and cardiovascular abnormalities, but also for the prevention of the syndrome. Expand
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
TLDR
This review attempts to cover the spectrum of metformin's cellular actions in different tissues and to summarize the current literature regarding the potential medical value of this medication in PCOS. Expand
Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
TLDR
Weight loss is a feature of protracted metformin therapy in obese women with PCOS, with greater weight reduction potentially achievable with higher doses, and additional studies are required to determine whether other aspects of the disorder may benefit from the higher dose of meetformin. Expand
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.
TLDR
Using polycystic ovary syndrome as a model of insulin resistance and hyperandrogenism, the effect of Metformin on lipoproteins, sex hormones, gonadotropins, and blood pressure in 26 women with PCOS was assessed. Expand
Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.
TLDR
It is demonstrated that a polymorphism in STK11, a kinase gene expressed in liver and implicated in meetformin action, is associated with ovulatory response to treatment with metformin alone in a prospective randomized trial. Expand
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
TLDR
The molecular mechanisms known to underlie the ovarian and metabolic abnormalities characterising PCOS are reviewed, and the putative interdependence between reproductive and metabolic aspects of PCOS, and therapeutic implications for the management of the syndrome are discussed. Expand
Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
TLDR
After metformin therapy, the atherogenic AGE molecules were reduced in the serum of women with PCOS, a high-risk group for type 2 diabetes mellitus and cardiovascular disease, remains to be seen. Expand
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
TLDR
It is confirmed that metformin treatment can lead to improvements in insulin resistance and ovarian hyperandrogenism. Expand
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
TLDR
Polycystic ovary syndrome appears to be a particularly common endocrine disorder in the Greek population under study and it is associated with certain metabolic abnormalities, suggesting that the severity of the fasting hyperinsulinemia isassociated with the severity with the clinical phenotype of hyperandrogenism independently of obesity. Expand
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
TLDR
Metformin does not improve weight loss or menstrual frequency in obese patients with PCOS, and weight loss alone through lifestyle changes improves menstrual frequency. Expand
...
1
2
3
4
5
...